Literature DB >> 175391

Excitation-mediating and inhibition-mediating dopamine-receptors: a new concept towards a better understanding of electrophysiological, biochemical, pharmacological, functional and clinical data.

A R Cools, J M Van Rossum.   

Abstract

A great number of earlier reported experimental data dealing with the role of dopamine in dopamine-loaded structures within the mammalian brain have raised questions concerning the concept of dopamine as an inhibitory agent acting on one type of receptor. A critical review of the anatomical, histochemical, electrophysiological, pharmacological and functional studies reveals that the dopamine-loaded structures are marked by an internal differentiation at various levels. It is attempted to demonstrate that this is due to a heterogeneous distribution of two distinct types of dopamine-receptors, each characterized by their own properties: DAe and DAi-receptors. Furthermore, the experimental and clinical implications are discussed in view of the hypothesis that balance between both types of receptors is essential for normal psychomotor functioning.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 175391     DOI: 10.1007/bf00421135

Source DB:  PubMed          Journal:  Psychopharmacologia


  25 in total

1.  MECHANISM OF ACTION OF PSYCHOMOTOR STIMULANT DRUGS. SIGNIFICANCE OF DOPAMINE IN LOCOMOTOR STIMULANT ACTION.

Authors:  A T HURKMANS
Journal:  Int J Neuropharmacol       Date:  1964-05

2.  Apomorphine in Parkinson's disease.

Authors:  R S SCHWAB; L V AMADOR; J Y LETTVIN
Journal:  Trans Am Neurol Assoc       Date:  1951

3.  Functional dissociation within the caudate nucleus of rats.

Authors:  G Winocur
Journal:  J Comp Physiol Psychol       Date:  1974-03

4.  Distribution and localization of sites of gamma aminobutyric acid metabolism in the adult rat brain.

Authors:  N Robinson; F Wells
Journal:  J Anat       Date:  1973-04       Impact factor: 2.610

5.  Possible dopaminergic pathway from substantia nigra to putamen.

Authors:  D H York
Journal:  Brain Res       Date:  1970-06-03       Impact factor: 3.252

6.  Dopamine: spontaneous and drug-induced release from the caudate nucleus in the cat.

Authors:  M Besson; A Cheramy; P Feltz; J Glowinski
Journal:  Brain Res       Date:  1971-09-24       Impact factor: 3.252

7.  Pharmacological analysis of dopamine-induced inhibition and excitation of neurones of the snail Helix aspersa.

Authors:  H A Boudier; W Geilen; A R Cools; J M Van Rossum
Journal:  Arch Int Pharmacodyn Ther       Date:  1974-06

8.  The developing neostriatum of the rabbit: correlation of fluorescence histochemistry, electron microscopy, endogenous dopamine levels, and ( 3 H)dopamine uptake.

Authors:  V M Tennyson; R E Barrett; G Cohen; L Côté; R Heikkila; C Mytilineou
Journal:  Brain Res       Date:  1972-11-13       Impact factor: 3.252

9.  Release by tubocurarine of dopamine and homovanillic acid from the superfused caudate nucleus.

Authors:  P J Portig; D F Sharman; M Vogt
Journal:  J Physiol       Date:  1968-02       Impact factor: 5.182

10.  Release to the cerebral ventricles of substances with possible transmitter function in the caudate nucleus.

Authors:  P J Portig; M Vogt
Journal:  J Physiol       Date:  1969-10       Impact factor: 5.182

View more
  60 in total

1.  Functional antagonism between dopamine and noradrenaline within the caudate nucleus of cats: a phenomenon of rhythmically changing susceptibility.

Authors:  A R Cools; P A van Dongen; H J Janssen; A A Megens
Journal:  Psychopharmacology (Berl)       Date:  1978-12-08       Impact factor: 4.530

2.  Inhibition-mediating dopamine receptors and the control of intracranial reward.

Authors:  R J Katz
Journal:  Psychopharmacology (Berl)       Date:  1979-03-14       Impact factor: 4.530

3.  Is morphine-induced catalepsy related to activation of dopaminergic neurones?

Authors:  P Moleman; D J Versluis; J Bruinvels
Journal:  Psychopharmacology (Berl)       Date:  1978-12-15       Impact factor: 4.530

4.  Dopaminergic mechanisms in schizophrenia.

Authors:  L L Iversen
Journal:  Proc R Soc Med       Date:  1977

5.  Editorial: Alternatives to levodopa.

Authors: 
Journal:  Br Med J       Date:  1976-05-15

6.  Behavioral and neuroendocrine effects of low dose ET-495: antagonism by haloperidol.

Authors:  B Angrist; M Ain; J Rotrosen; S Gershon; F S Halpern; E J Sachar
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

7.  Tiapride in levodopa-induced involuntary movements.

Authors:  A J Lees; C M Lander; G M Stern
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-04       Impact factor: 10.154

8.  Dopamine receptors in canine caudate nucleus.

Authors:  H Maeno
Journal:  Mol Cell Biochem       Date:  1982-03-19       Impact factor: 3.396

9.  Oxiperomide in tardive dyskinesia.

Authors:  D E Casey; J Gerlach
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-03       Impact factor: 10.154

10.  Neuroleptic properties of cis-N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-methylaminobenzamide (YM-09151-2) with selective antidopaminergic activity.

Authors:  S Usuda; K Nishikori; O Noshiro; H Maeno
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.